Stephen Maxted Ansell, MD, PhD

  • 20991 Citations
  • 77 Scopus h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1983 2019

Filter
Article
2019

Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma

Wang, Y., Wenzl, K., Manske, M. K., Asmann, Y., Sarangi, V., Greipp, P. T., Krull, J. E., Hartert, K., He, R., Feldman, A. L., Maurer, M. J., Slager, S. L., Nowakowski, G. S., Habermann, T. M., Witzig, T. E., Link, B. K., Ansell, S. M., Cerhan, J. R. & Novak, A. J., Sep 1 2019, In : Blood cancer journal. 9, 9, 73.

Research output: Contribution to journalArticle

Open Access
Lymphoma, Large B-Cell, Diffuse
B-Cell Lymphoma
Immunotherapy
Lymphoma
Hodgkin Disease

An RNA aptamer-based biomarker platform demonstrates high soluble cd25 occupancy by il2 in the serum of follicular lymphoma patients

Veeramani, S., Blackwell, S. E., Thiel, W. H., Yang, Z. Z., Ansell, S. M., Giangrande, P. H. & Weiner, G. J., Jan 1 2019, In : Cancer Immunology Research. 7, 9, p. 1511-1522 12 p.

Research output: Contribution to journalArticle

Nucleotide Aptamers
Follicular Lymphoma
Biomarkers
Ligands
Serum

Autograft immune content and survival in non-Hodgkin's lymphoma: A post hoc analysis

Porrata, L. F., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Villasboas Bisneto, J. J. C. . & Markovic, S. N., Jun 1 2019, In : Leukemia Research. 81, p. 1-9 9 p.

Research output: Contribution to journalArticle

Autografts
Peripheral Blood Stem Cell Transplantation
Hematopoietic Stem Cell Transplantation
Non-Hodgkin's Lymphoma
Survival

Bleomycin use in the treatment of Hodgkin lymphoma (HL): toxicity and outcomes in the modern era

Taparra, K., Liu, H., Polley, M. Y., Ristow, K., Habermann, T. M. & Ansell, S. M., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Bleomycin
Hodgkin Disease
Lung
Therapeutics
indium-bleomycin
6 Citations (Scopus)

Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma

Ramchandren, R., Advani, R. H., Ansell, S. M., Bartlett, N. L., Chen, R., Connors, J. M., Feldman, T., Forero-Torres, A., Friedberg, J. W., Gopal, A. K., Gordon, L. I., Kuruvilla, J., Savage, K. J., Younes, A., Engley, G., Manley, T. J., Fenton, K. & Straus, D. J., Jan 1 2019, In : Clinical Cancer Research. 25, 6, p. 1718-1726 9 p.

Research output: Contribution to journalArticle

Open Access
North America
Hodgkin Disease
Drug Therapy
Disease-Free Survival
Febrile Neutropenia
8 Citations (Scopus)

Cause of death in follicular lymphoma in the first decade of the rituximab era: A pooled analysis of French and US cohorts

Sarkozy, C., Maurer, M. J., Link, B. K., Ghesquieres, H., Nicolas, E., Thompson, C. A., Traverse-Glehen, A., Feldman, A. L., Allmer, C., Slager, S. L., Ansell, S. M., Habermann, T. M., Bachy, E., Cerhan, J. R. & Salles, G., Jan 10 2019, In : Journal of Clinical Oncology. 37, 2, p. 144-152 9 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Cause of Death
Lymphoma
Disease-Free Survival
Rituximab
Follicular Lymphoma
Spleen
Bone and Bones
Survival
Disease-Free Survival
4 Citations (Scopus)

Ibrutinib for the treatment of Bing-Neel syndrome: A multicenter study

Castillo, J. J., Itchaki, G., Paludo, J., Varettoni, M., Buske, C., Eyre, T. A., Chavez, J. C., Shain, K. H., Issa, S., Palomba, M. L., Pasvolsky, O., Simpson, D., Talaulikar, D., Tam, C. S., Tedeschi, A., Ansell, S. M., Nayak, L. & Treon, S. P., Jan 24 2019, In : Blood. 133, 4, p. 299-305 7 p.

Research output: Contribution to journalArticle

Multicenter Studies
Survival
Waldenstrom Macroglobulinemia
Confidence Intervals
Therapeutics
Waldenstrom Macroglobulinemia
Clinical Trials
Confidence Intervals
Disease-Free Survival
Immunoglobulin M

Impact of metformin use on the outcomes of newly diagnosed diffuse large B-cell lymphoma and follicular lymphoma

Wang, Y., Maurer, M. J., Larson, M. C., Allmer, C., Feldman, A. L., Bennani, N., Thompson, C. A., Porrata, L. F., Habermann, T. M., Witzig, T. E., Ansell, S. M., Slager, S. L., Nowakowski, G. S. & Cerhan, J. R., Sep 1 2019, In : British journal of haematology. 186, 6, p. 820-828 9 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Lymphoma, Large B-Cell, Diffuse
Metformin
Diabetes Mellitus
Confidence Intervals
1 Citation (Scopus)

Late relapses in patients with diffuse large b-cell lymphoma treated with immunochemotherapy

Wang, Y., Farooq, U., Link, B. K., Larson, M. C., King, R., Maurer, M. J., Allmer, C., Hefazi, M., Thompson, C. A., Micallef, I., Johnston, P. B., Habermann, T. M., Witzig, T. E., Ansell, S. M., Cerhan, J. R. & Nowakowski, G. S., Jul 20 2019, In : Journal of Clinical Oncology. 37, 21, p. 1819-1827 9 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Lymphoma
Recurrence
Germinal Center
B-Lymphocytes
2 Citations (Scopus)

Mass Cytometry Analysis Reveals that Specific Intratumoral CD4 + T Cell Subsets Correlate with Patient Survival in Follicular Lymphoma

Yang, Z. Z., Kim, H. J., Villasboas Bisneto, J. J. C. ., Price-Troska, T., Jalali, S., Wu, H., Luchtel, R., Polley, M-Y., Novak, A. J. & Ansell, S. M., Feb 19 2019, In : Cell reports. 26, 8, p. 2178-2193.e3

Research output: Contribution to journalArticle

Open Access
Follicular Lymphoma
T-cells
T-Lymphocyte Subsets
T-Lymphocytes
Survival
7 Citations (Scopus)

Nivolumab for newly diagnosed advanced-stage classic Hodgkin lymphoma: Safety and efficacy in the phase II CheckMate 205 study

Ramchandren, R., Domingo-Domènech, E., Rueda, A., Trněný, M., Feldman, T. A., Lee, H. J., Provencio, M., Sillaber, C., Cohen, J. B., Savage, K. J., Willenbacher, W., Ligon, A. H., Ouyang, J., Redd, R., Rodig, S. J., Shipp, M. A., Sacchi, M., Sumbul, A., Armand, P. & Ansell, S. M., Aug 10 2019, In : Journal of Clinical Oncology. 37, 23, p. 1997-2007 11 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Safety
Disease-Free Survival
Reed-Sternberg Cells
Ligands
15 Citations (Scopus)

Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study

Ansell, S. M., Minnema, M. C., Johnson, P., Timmerman, J. M., Armand, P., Shipp, M. A., Rodig, S. J., Ligon, A. H., Roemer, M. G. M., Reddy, N., Cohen, J. B., Assouline, S., Poon, M., Sharma, M., Kato, K., Samakoglu, S., Sumbul, A. & Grigg, A., Feb 20 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 6, p. 481-489 9 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Autologous Transplantation
Cell Transplantation
Safety
nivolumab

Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?

Novo, M., Nowakowski, G. S., Habermann, T. M., Witzig, T. E., Micallef, I. N., Johnston, P. B., Inwards, D. J., Botto, B., Ristow, K. M., Young, J. R., Vitolo, U. & Ansell, S. M., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Hodgkin Disease
Biopsy
Salvage Therapy
Therapeutics
Positron Emission Tomography Computed Tomography
2 Citations (Scopus)

Reverse signaling via PD-L1 supports malignant cell growth and survival in classical Hodgkin lymphoma

Jalali, S., Price-Troska, T., Bothun, C., Villasboas Bisneto, J. J. C. ., Kim, H. J., Yang, Z. Z., Novak, A. J., Dong, H. M. & Ansell, S. M., Mar 1 2019, In : Blood cancer journal. 9, 3, 22.

Research output: Contribution to journalArticle

Hodgkin Disease
Cell Survival
Growth
Ligands
Cell Line

SIRPα expression delineates subsets of intratumoral monocyte/macrophages with different functional and prognostic impact in follicular lymphoma

Chen, Y. P., Kim, H. J., Wu, H., Price-Troska, T., Villasboas, J. C., Jalali, S., Feldman, A. L., Novak, A. J., Yang, Z. Z. & Ansell, S. M., Oct 1 2019, In : Blood cancer journal. 9, 10, 84.

Research output: Contribution to journalArticle

Open Access
Follicular Lymphoma
Monocytes
Macrophages
Cytophagocytosis
Proteins
1 Citation (Scopus)

Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma

Wu, X., Stenson, M., Abeykoon, J., Nowakowski, K., Zhang, L., Lawson, J., Wellik, L., Li, Y., Krull, J., Wenzl, K., Novak, A. J., Ansell, S. M., Bishop, G. A., Billadeau, D. D., Peng, K. W., Giles, F., Schmitt, D. M. & Witzig, T. E., Jul 25 2019, In : Blood. 134, 4, p. 363-373 11 p.

Research output: Contribution to journalArticle

Glycogen Synthase Kinase 3
Lymphoma
Therapeutics
B-Lymphocytes
Clustered Regularly Interspaced Short Palindromic Repeats

The highs and lows of immune-checkpoint blockade in lymphoma

Ansell, S. M., May 1 2019, In : Cancer Immunology Research. 7, 5, p. 696-700 5 p.

Research output: Contribution to journalArticle

Lymphoma
Non-Hodgkin's Lymphoma
Neoplasms
Hodgkin Disease
Immune System Diseases
20 Citations (Scopus)

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis

Wang, Y., Zhou, S., Yang, F., Qi, X., Wang, X., Guan, X., Shen, C., Duma, N., Vera Aguilera, J., Chintakuntlawar, A., Price, K. A., Molina, J. R., Pagliaro, L. C., Halfdanarson, T. R., Grothey, A. F., Markovic, S. N., Nowakowski, G. S., Ansell, S. M. & Wang, M. L., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journalArticle

CD274 Antigen
Meta-Analysis
Clinical Trials
Incidence
Odds Ratio
1 Citation (Scopus)

Two types of amyloidosis presenting in a single patient: a case series

Sidiqi, M. H., McPhail, E., Theis, J. D., Dasari, S., Vrana, J. A., Drosou, M. E., Leung, N., Hayman, S., Rajkumar, S. V., Warsame, R., Ansell, S. M., Gertz, M., Grogan, M. & Dispenzieri, A., Mar 1 2019, In : Blood cancer journal. 9, 3, 30.

Research output: Contribution to journalArticle

Amyloidosis
Amyloid
Immunoglobulins
Amyloidogenic Proteins
Paraproteinemias
2018
34 Citations (Scopus)

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts

Huet, S., Tesson, B., Jais, J. P., Feldman, A. L., Magnano, L., Thomas, E., Traverse-Glehen, A., Albaud, B., Carrère, M., Xerri, L., Ansell, S. M., Baseggio, L., Reyes, C., Tarte, K., Boyault, S., Haioun, C., Link, B. K., Feugier, P., Lopez-Guillermo, A., Tilly, H. & 10 others, Brice, P., Hayette, S., Jardin, F., Offner, F., Sujobert, P., Gentien, D., Viari, A., Campo, E., Cerhan, J. R. & Salles, G., Apr 1 2018, In : The Lancet Oncology. 19, 4, p. 549-561 13 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Gene Expression Profiling
Disease-Free Survival
Paraffin
Formaldehyde

A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma

Padrnos, L., Ernst, B., Dueck, A., Kosiorek, H. E., Ginos, B. F., Toro, A., Johnston, P. B., Habermann, T. M., Leis, J. F., Mikhael, J. R., Nowakowski, G. S., Colgan, J., Porrata, L., Ansell, S. M., Witzig, T. E. & Reeder, C., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Lymphoma
Pharmaceutical Preparations
Maximum Tolerated Dose
Neutropenia
Hodgkin Disease
1 Citation (Scopus)

A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma

Sonbol, M. B., Hilal, T., Dueck, A., Rosenthal, A. C., Conley, C. R., Kosiorek, H. E., Ginos, B. F., Gano, K. M., Nichols, C. S., Leis, J. F., Johnston, P. B., Habermann, T. M., Northfelt, D. W., Bergsagel, P. L., Inwards, D. J., Witzig, T. E., Ansell, S. M. & Reeder, C. B., Jan 11 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-7 7 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Cyclophosphamide
Dexamethasone
Safety
Peripheral Nervous System Diseases
16 Citations (Scopus)

A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy

Bachy, E., Maurer, M. J., Habermann, T. M., Gelas-Dore, B., Maucort-Boulch, D., Estell, J. A., Van den Neste, E., Bouabdallah, R., Gyan, E., Feldman, A. L., Bargay, J., Delmer, A., Slager, S. L., da Silva, M. G., Fitoussi, O., Belada, D., Maisonneuve, H., Intragumtornchai, T., Ansell, S. M., Lamy, T. & 5 others, Dartigues, P., Link, B. K., Seymour, J. F., Cerhan, J. R. & Salles, G., Jul 5 2018, In : Blood. 132, 1, p. 49-58 10 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Disease-Free Survival
Bone
Bone Marrow
Chemotherapy
9 Citations (Scopus)

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

Paludo, J., Abeykoon, J. P., Shreders, A., Ansell, S. M., Kumar, S. K., Ailawadhi, S., King, R., Koehler, A. B., Reeder, C. B., Buadi, F. K., Dispenzieri, A., Lacy, M., Dingli, D. M., Witzig, T. E., Go, R. S., Gonsalves, W., Kourelis, T., Warsame, R., Leung, N., Habermann, T. M. & 6 others, Hayman, S., Lin, Y., Kyle, R. A., Rajkumar, S. V., Gertz, M. & Kapoor, P., Apr 3 2018, (Accepted/In press) In : Annals of Hematology. p. 1-9 9 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Cyclophosphamide
Dexamethasone
Disease-Free Survival
Bendamustine Hydrochloride
25 Citations (Scopus)

Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma

LaCasce, A. S., Gregory Bociek, R., Sawas, A., Caimi, P., Agura, E., Matous, J., Ansell, S. M., Crosswell, H. E., Islas-Ohlmayer, M., Behler, C., Cheung, E., Forero-Torres, A., Vose, J., O’Connor, O. A., Josephson, N., Wang, Y. & Advani, R., Jul 5 2018, In : Blood. 132, 1, p. 40-48 9 p.

Research output: Contribution to journalArticle

Salvaging
Stem cells
Hodgkin Disease
Refractory materials
Stem Cell Transplantation
130 Citations (Scopus)

Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin's lymphoma

Connors, J. M., Jurczak, W., Straus, D. J., Ansell, S. M., Kim, W. S., Gallamini, A., Younes, A., Alekseev, S., Illés, A., Picardi, M., Lech-Maranda, E., Oki, Y., Feldman, T., Smolewski, P., Savage, K. J., Bartlett, N. L., Walewski, J., Chen, R., Ramchandren, R., Zinzani, P. L. & 9 others, Cunningham, D., Rosta, A., Josephson, N. C., Song, E., Sachs, J., Liu, R., Jolin, H. A., Huebner, D. & Radford, J., Jan 25 2018, In : New England Journal of Medicine. 378, 4, p. 331-344 14 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Drug Therapy
Confidence Intervals
Dacarbazine
Vinblastine
17 Citations (Scopus)
Hematologic Neoplasms
Multiple Myeloma
Outcome Assessment (Health Care)
Mortality
Follicular Lymphoma

Defining lymphoplasmacytic lymphoma: Does MYD88L265P define a pathologically distinct entity among patients with an IgM paraprotein and bone marrow-based low-grade b-cell lymphomas with plasmacytic differentiation?

Fang, H., Kapoor, P., Gonsalves, W., Frederick, L. A., Viswanatha, D., Howard, M. T., He, R., Morice, W. G., McPhail, E., Greipp, P. T., Ansell, S. M., Kyle, R. A., Gertz, M., Paludo, J., Abeykoon, J. & King, R., Jul 3 2018, In : American Journal of Clinical Pathology. 150, 2, p. 168-176 9 p.

Research output: Contribution to journalArticle

Paraproteins
Immunoglobulin M
Lymphoma
Bone Marrow
Waldenstrom Macroglobulinemia
21 Citations (Scopus)

Diagnosis-to-treatment interval is an important clinical factor in newly diagnosed diffuse large B-cell lymphoma and has implication for bias in clinical trials

Maurer, M. J., Ghesquières, H., Link, B. K., Jais, J. P., Habermann, T. M., Thompson, C. A., Haioun, C., Allmer, C., Johnston, P. B., Delarue, R., Micallef, I., Peyrade, F., Inwards, D. J., Ketterer, N., Farooq, U., Fitoussi, O., Macon, W. R., Molina, T. J., Syrbu, S., Feldman, A. L. & 8 others, Slager, S. L., Weiner, G. J., Ansell, S. M., Cerhan, J. R., Salles, G. A., Witzig, T. E., Tilly, H. & Nowakowski, G. S., Jun 1 2018, In : Journal of Clinical Oncology. 36, 16, p. 1603-1610 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Clinical Trials
Lymphoma
Therapeutics
Selection Bias
8 Citations (Scopus)

Hodgkin lymphoma: 2018 update on diagnosis, risk-stratification, and management

Ansell, S. M., May 1 2018, In : American Journal of Hematology. 93, 5, p. 704-715 12 p.

Research output: Contribution to journalArticle

Risk Management
Hodgkin Disease
Standard of Care
Transplants
Drug Therapy
7 Citations (Scopus)

Human Pegivirus infection and lymphoma risk and prognosis: A North American study

Fama, A., Xiang, J., Link, B. K., Allmer, C., Klinzman, D., Feldman, A. L., Nowakowski, G. S., Liebow, M., Larson, M. C., Maurer, M. J., Ansell, S. M., Novak, A. J., Asmann, Y., Slager, S. L., Call, T. G., Habermann, T. M., Cerhan, J. R. & Stapleton, J. T., Jan 1 2018, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Lymphoma
Infection
Viremia
B-Cell Chronic Lymphocytic Leukemia
Confidence Intervals

Immunophenotype switching in cutaneous T-cell lymphoma: nature or nurture?

Ansell, S. M., Jan 1 2018, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Cutaneous T-Cell Lymphoma
10 Citations (Scopus)

Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements

McPhail, E., Maurer, M. J., Macon, W. R., Feldman, A. L., Kurtin, P. J., Ketterling, R. P., Vaidya, R., Cerhan, J. R., Ansell, S. M., Porrata, L. F., Nowakowski, G. S., Witzig, T. E. & Habermann, T. M., Nov 1 2018, In : Haematologica. 103, 11, p. 1899-1907 9 p.

Research output: Contribution to journalArticle

Gene Rearrangement
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Vincristine
Survival
3 Citations (Scopus)
Autografts
Stem Cell Transplantation
HLA-DR Antigens
Natural Killer Cells
Lymphoma

Inhibiting IL-2 signaling and the regulatory T-cell pathway using computationally designed peptides

Price-Troska, T., Yang, Z. Z., Diller, D., Bayden, A., Jarosinski, M., Audie, J. & Ansell, S. M., Apr 26 2018, (Accepted/In press) In : Investigational New Drugs. p. 1-8 8 p.

Research output: Contribution to journalArticle

Regulatory T-Lymphocytes
Interleukin-2
Peptides
B-Cell Lymphoma
T-Lymphocytes
68 Citations (Scopus)

Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma

Herrera, A. F., Moskowitz, A. J., Bartlett, N. L., Vose, J. M., Ramchandren, R., Feldman, T. A., LaCasce, A. S., Ansell, S. M., Moskowitz, C. H., Fenton, K., Ogden, C. A., Taft, D., Zhang, Q., Kato, K., Campbell, M. & Advani, R. H., Mar 15 2018, In : Blood. 131, 11, p. 1183-1194 12 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Refractory materials
Salvaging
T-cells
Stem cells
6 Citations (Scopus)
Waldenstrom Macroglobulinemia
Lymphoproliferative Disorders
Immunoglobulin M
B-Lymphocytes
Kidney
5 Citations (Scopus)

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials

Castellino, A., Chiappella, A., LaPlant, B. R., Pederson, L. D., Gaidano, G., Macon, W. R., Inghirami, G., Reeder, C. B., Tucci, A., King, R., Congiu, A., Foran, J. M., Pavone, V., Rivera, C. E., Spina, M., Ansell, S. M., Cavallo, F., Molinari, A. L., Ciccone, G., Habermann, T. M. & 3 others, Witzig, T. E., Vitolo, U. & Nowakowski, G. S., Nov 1 2018, In : Blood Cancer Journal. 8, 11, 108.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Disease-Free Survival
Survival
Neoplasms
Germinal Center
1 Citation (Scopus)

Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma

Wenzl, K., Manske, M. K., Sarangi, V., Asmann, Y., Greipp, P. T., Schoon, H. R., Braggio, E. D., Maurer, M. J., Feldman, A. L., Witzig, T. E., Slager, S. L., Ansell, S. M., Cerhan, J. R. & Novak, A. J., Oct 1 2018, In : Blood Cancer Journal. 8, 10, 97.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Lymphoma, Large B-Cell, Diffuse
Non-Hodgkin's Lymphoma
Mutation
Up-Regulation
59 Citations (Scopus)

Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic Hodgkin lymphoma

Roemer, M. G. M., Redd, R. A., Cader, F. Z., Pak, C. J., Abdelrahman, S., Ouyang, J., Sasse, S., Younes, A., Fanale, M., Santoro, A., Zinzani, P. L., Timmerman, J., Collins, G. P., Ramchandren, R., Cohen, J. B., De Boer, J. P., Kuruvilla, J., Savage, K. J., Trneny, M., Ansell, S. M. & 9 others, Kato, K., Farsaci, B., Sumbul, A., Armand, P., Neuberg, D. S., Pinkus, G. S., Ligon, A. H., Rodig, S. J. & Shipp, M. A., Apr 1 2018, In : Journal of Clinical Oncology. 36, 10, p. 942-950 9 p.

Research output: Contribution to journalArticle

Reed-Sternberg Cells
Major Histocompatibility Complex
Hodgkin Disease
Ligands
Disease-Free Survival
11 Citations (Scopus)

Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements

Luchtel, R., Dasari, S., Oishi, N., Pedersen, M. B., Hu, G., Rech, K. L., Ketterling, R. P., Sidhu, J., Wang, X., Katoh, R., Dogan, A., Kip, N. S., Cunningham, J. M., Sun, Z., Baheti, S., Porcher, J. C., Said, J. W., Jiang, L., Hamilton-Dutoit, S. J., Møller, M. B. & 10 others, Nørgaard, P., Bennani, N., Chng, W. J., Huang, G., Link, B. K., Facchetti, F., Cerhan, J. R., D’Amore, F., Ansell, S. M. & Feldman, A. L., Sep 27 2018, In : Blood. 132, 13, p. 1386-1398 13 p.

Research output: Contribution to journalArticle

Anaplastic Large-Cell Lymphoma
Cues
Genes
T-cells
DNA
12 Citations (Scopus)

MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia

Abeykoon, J. P., Paludo, J., King, R., Ansell, S. M., Gertz, M., LaPlant, B. R., Halvorson, A. E., Gonsalves, W., Dingli, D. M., Fang, H., Rajkumar, S. V., Lacy, M., He, R., Kourelis, T., Reeder, C. B., Novak, A. J., McPhail, E., Viswanatha, D. S., Witzig, T. E., Go, R. S. & 10 others, Habermann, T. M., Buadi, F. K., Dispenzieri, A., Leung, N., Lin, Y., Thompson, C. A., Hayman, S. R., Kyle, R. A., Kumar, S. K. & Kapoor, P., Feb 1 2018, In : American Journal of Hematology. 93, 2, p. 187-194 8 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Mutation
Survival
Genotype
Myelodysplastic Syndromes
87 Citations (Scopus)

Nivolumab for relapsed/refractory classic hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: Extended follow-up of the multicohort single-arm phase II checkmate 205 trial

Armand, P., Engert, A., Younes, A., Fanale, M., Santoro, A., Zinzani, P. L., Timmerman, J. M., Collins, G. P., Ramchandren, R., Cohen, J. B., De Boer, J. P., Kuruvilla, J., Savage, K. J., Trneny, M., Shipp, M. A., Kato, K., Sumbul, A., Farsaci, B. & Ansell, S. M., May 10 2018, In : Journal of Clinical Oncology. 36, 14, p. 1428-1439 12 p.

Research output: Contribution to journalArticle

Cell Transplantation
Hodgkin Disease
Disease Progression
Safety
Advisory Committees
4 Citations (Scopus)

Outcomes among North American patients with diffuse large b-cell lymphoma are independent of tumor Epstein-Barr virus positivity or immunosuppression

Tracy, S. I., Habermann, T. M., Feldman, A. L., Maurer, M. J., Dogan, A., Perepu, U. S., Syrbu, S., Ansell, S. M., Thompson, C. A., Weiner, G. J., Nowakowski, G. S., Allmer, C., Slager, S. L., Witzig, T. E., Cerhan, J. R. & Link, B. K., Jan 31 2018, In : Haematologica. 103, 2, p. 297-303 7 p.

Research output: Contribution to journalArticle

Oncogenic Viruses
Lymphoma, Large B-Cell, Diffuse
Human Herpesvirus 4
Immunosuppression
Confidence Intervals
5 Citations (Scopus)

PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness

He, R., Ding, W. D., Viswanatha, D. S., Chen, D., Shi, M., Van Dyke, D., Tian, S., Dao, L. N., Parikh, S. A., Shanafelt, T. D., Call, T. G., Ansell, S. M., Leis, J. F., Mai, M., Hanson, C. A. & Rech, K. L., Jan 1 2018, In : American Journal of Surgical Pathology. 42, 7, p. 843-854 12 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
B-Lymphocytes
Biomarkers
Immunotherapy
Neoplasms

Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia

Abeykoon, J. P., Zanwar, S., Ansell, S. M., Winters, J., Gertz, M., King, R., Murray, D., Habermann, T. M., Dingli, D. M., Muchtar, E., Go, R. S., Leung, N., Inwards, D. J., Buadi, F. K., Dispenzieri, A., Lacy, M., Lin, Y., Gonsalves, W., Kourelis, T., Witzig, T. E. & 5 others, Thompson, C. A., Rajkumar, S. V., Kyle, R. A., Kumar, S. K. & Kapoor, P., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Immunoglobulin M
Viscosity
Serum
Survival
2 Citations (Scopus)

Prevalence, clinical characteristics and prognosis of EBV-positive follicular lymphoma

Mackrides, N., Chapman, J., Larson, M. C., Ramos, J. C., Toomey, N., Lin, P., Maurer, M. J., Rafaelle, M., Tan, Y., Ikpatt, O., Syrbu, S., Ansell, S. M., Habermann, T. M., Link, B. K., Feldman, A. L., Lossos, I. S., Cerhan, J. R. & Vega, F., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Follicular Lymphoma
Human Herpesvirus 4

Primary systemic amyloidosis in patients with Waldenström macroglobulinemia

Zanwar, S., Abeykoon, J. P., Ansell, S. M., Gertz, M., Dispenzieri, A., Muchtar, E., Sidana, S., Tandon, N., Rajkumar, S. V., Dingli, D. M., Go, R., Lacy, M., Kourelis, T., Witzig, T. E., Inwards, D., Buadi, F., Gonsalves, W., Habermann, T. M., Johnston, P. B., Nowakowski, G. S. & 3 others, Kyle, R. A., Kumar, S. K. & Kapoor, P., Jan 1 2018, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Primary amyloidosis